132 related articles for article (PubMed ID: 18763362)
1. ARBs vs. ACE inhibitors: which is better for hypertension? ACE inhibitors are generally preferable, but ARBs offer an effective alternative for patients suffering side effects.
Heart Advis; 2008 Jul; 11(7):4. PubMed ID: 18763362
[No Abstract] [Full Text] [Related]
2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure drugs compared. ACE inhibitors beat ARBs hands-down for survival benefit.
Harv Heart Lett; 2012 Jun; 22(10):5. PubMed ID: 22764400
[No Abstract] [Full Text] [Related]
4. Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies.
Hao G; Wang Z; Guo R; Chen Z; Wang X; Zhang L; Li W
BMC Cardiovasc Disord; 2014 Oct; 14():148. PubMed ID: 25344747
[TBL] [Abstract][Full Text] [Related]
5. Management of hypertension in patients with chronic kidney disease and diabetes mellitus.
Palmer BF
Am J Med; 2008 Aug; 121(8 Suppl):S16-22. PubMed ID: 18638614
[TBL] [Abstract][Full Text] [Related]
6. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
Gerc V; Buksa M; Loza V; Kulic M
Med Arh; 2009; 63(6):343-9. PubMed ID: 20380117
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
Grothusen A; Divchev D; Luchtefeld M; Schieffer B
Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
[TBL] [Abstract][Full Text] [Related]
8. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
[TBL] [Abstract][Full Text] [Related]
9. Achieving blood pressure goals: should angiotensin II receptor blockers become first-line treatment in hypertension?
Weber M
J Hypertens Suppl; 2009 Jul; 27(5):S9-14. PubMed ID: 19587555
[TBL] [Abstract][Full Text] [Related]
10. Hypertension management in outpatient visits by diabetic patients.
Aparasu RR; Aparasu A
Res Social Adm Pharm; 2008 Sep; 4(3):284-91. PubMed ID: 18794038
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
Epstein BJ; Gums JG
Ann Pharmacother; 2005 Mar; 39(3):470-80. PubMed ID: 15701766
[TBL] [Abstract][Full Text] [Related]
12. Recent changes in the landscape of combination RAS blockade.
Epstein BJ; Smith SM; Choksi R
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.
Abuissa H; Jones PG; Marso SP; O'Keefe JH
J Am Coll Cardiol; 2005 Sep; 46(5):821-6. PubMed ID: 16139131
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
15. New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Weber MA
Am J Cardiol; 2007 Aug; 100(3A):45J-52J. PubMed ID: 17666198
[TBL] [Abstract][Full Text] [Related]
16. Use of ACE inhibitors and ARBs in hypertensive women of childbearing age.
Martin U; Foreman MA; Travis JC; Casson D; Coleman JJ
J Clin Pharm Ther; 2008 Oct; 33(5):507-11. PubMed ID: 18834365
[TBL] [Abstract][Full Text] [Related]
17. Is the jury out? Class specific differences on coronary outcomes with ACE-inhibitors and ARBs: insight from meta-analysis and The Blood Pressure Lowering Treatment Trialists' Collaboration.
Strauss MH; Lonn EM; Verma S
Eur Heart J; 2005 Nov; 26(22):2351-3. PubMed ID: 16219656
[No Abstract] [Full Text] [Related]
18. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
Ghanem FA; Movahed A
Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
[TBL] [Abstract][Full Text] [Related]
19. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step?
Hollenberg NK
Rev Cardiovasc Med; 2007; 8 Suppl 2():S7-13. PubMed ID: 17401314
[TBL] [Abstract][Full Text] [Related]
20. ACE inhibitors and ARBs: antihypertensive medications in CKD.
Szromba C
Nephrol Nurs J; 2005; 32(3):332-3. PubMed ID: 16035474
[No Abstract] [Full Text] [Related]
[Next] [New Search]
